Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06386848
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-01-18
Brief Title:
Strategy to Adapt Botulinum Toxin Doses in Dystonia
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Strategy to Adapt Botulinum Toxin Doses in Dystonia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended
We we ll study the increase of the dose injected over the time the side effects
The hypothesis is that we inject smaller doses than we could regarding the recommandations
We we ll study the increase of the dose injected over the time the side effects
The hypothesis is that we inject smaller doses than we could regarding the recommandations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None